TTP and Start Codon to support life science start-ups in new partnership
Posted on Sep 15, 2020 by Cambridge Catalyst
The collaboration aims to strengthen Start Codon’s support for life science and healthcare start-ups, with TTP providing technical consultancy, to fast-track technology development and commercialisation
Pictured: Dr Jason Mellad, CEO of Start Codon
Technology and product development company TTP has this month announced a new partnership with life science business accelerator Start Codon, in a bid to provide entrepeneurs with mentoring and tech consultancy, accelerate product development and eventual commercialisation.
TTP will be delivering a virtual seminar on 17 September focussing on product development and commercialisation, as part of Start Codon and Cancer Research UK’s Entrepreneurial Training Scheme.
Dr Michelle Griffin, Clinical Innovator at TTP commented, “We are delighted to be working with Start Codon to help support their talented network. This partnership allows Start Codon and its cohort companies to tap into our experience in developing products and services that deliver recurrent successful clinical, scientific and financial outcomes.”
Start Codon aims to identify and recruit high-potential life science and healthcare companies from across the UK and beyond, provide seed-funding, and leverage the world-class resources of the Cambridge Cluster to reduce risk and prepare for a successful Series A fundraise. Under the terms of the partnership, Start Codon cohort companies will receive technology consultancy from TTP via one-to-one meetings and networking events throughout Start Codon’s six month ‘programme cycles.’ Both partners have committed to using their complementary networks and knowledge-base to co-host conferences and talks. Start Codon will promote TTP to their portfolio, thus helping TTP to connect with potential collaborators.
In Cambridge Catalyst’s second issue, we had the opportunity to interview the CEO of Start Codon, Dr Jason Mellad, for our Big 3 section, which asks business leaders who their biggest influences are. He was able to grow his business through winning the Lion’s Den business plan competition, which offers start-up capital to entrepreneurs. The importance of investment and product development is something Mellad has realised throughout his career, which may be part of what influenced the partnership.
He comments, “Product development plays a critical role in the growth of new companies. Having insight from TTP – who are recognised thought-leaders and experts in the life science and healthcare space – will strengthen our programme offering from this perspective, so we can help more companies translate their innovations into the clinic.”
Early stage start-up companies in the life sciences and healthcare space are invited to apply to the Start Codon accelerator programme by clicking here.
Read the latest issue of Cambridge Catalyst here.